Effect of Ocrelizumab on Neuroinflammation in Multiple Sclerosis as Measured by 11C-PBR28 MR-PET Imaging of Microglia Activation
Clinical trial NCT04230174 · COMPLETED
Trial details
- NCT number
- NCT04230174
- Sponsor
- Massachusetts General Hospital
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-29
- Primary completion
- 2024-10-09
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.